What Does it Mean for Shareholders When Trusts Issue New Shares?

Woodford Patient Capital Trust announced it would be issuing new shares last week thanks to demand from investors. But how does this affect existing shareholders?

Jeremy Beckwith 17 August, 2015 | 12:13AM
Facebook Twitter LinkedIn

 

 

 

 

Jeremy Beckwith: So one of the most important features of investment trust, is that the share price is determined by buyers and sellers and the price at which they are happy to transact. This can be very different from the actual value of the assets within the investment trust. So what we've seen particularly with the Woodford Patient Capital Trust over the course of this year is that share price has gone up and up as everybody wanted to buy their shares at a much faster rate than the actual value of the assets inside the fund.

Earlier this week the share price got to be about 120p whilst the assets in the fund were only worth about 105p, so a very big discrepancy. So the Woodford Patient Capital Trust decided this week to sell more shares, because there is a lot of demand for them. So they were able to sell another large slug of shares at 115p.

Now for shareholders this has two effects, one negative and one positive. The short term negative effect is that share price fell from 120 to 115 because of this placing of shares. However on a longer term basis if you look at what's actually the real value of the company the underlying assets of the company they have actually gone up, because the company was able to sell shares for more than they are actually worth, and therefore their asset value per share has actually gone up because of this transaction. 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Jeremy Beckwith  is Director of Manager Research for Morningstar UK

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures